Spregledana korist neoadjuvantne kemoterapije v zdravljenju mišično invazivnega raka sečnega mehurja

Autor: Andrej Žist, Tomaž Milanez, Breda Škrbinc, Vesna Zadnik, Boštjan Šeruga

Publikováno v: Onkologija, Vol 16, Iss 2, Pp 74-77 (2012)

Rak sečnega mehurja predstavlja tretji najpogostejši malignom genitourinarnega trakta, incidenca in umrljivost za rakom sečnega mehurja pa sta v Sloveniji v porastu. V radikalnem zdravljenju mišično invazivnega raka sečnega mehurja je ključneg

Externí odkaz: https://doaj.org/article/a846f8bf54554e919ac960a5bcafdc1e

Driska in zaprtje

Autor: Breda Škrbinc

Publikováno v: Onkologija, Vol 13, Iss 1, Pp 47-50 (2009)

Driska (diareja) in zaprtje (obstipacija) sta relativno pogosta bolezenska znaka bolnikov z rakom. Pojavljata se kot znaka osnovne rakave bolezni ali kot posledici specifičnega onkološkega zdravljenja, to je operativnega zdravljenja, zdravljenja z

Externí odkaz: https://doaj.org/article/fdd478120baf4eb092e45a055689b49d

Germinalni tumorji

Autor: Breda Škrbinc

Publikováno v: Onkologija, Vol 13, Iss 2, Pp 114-116 (2009)

Germinalni tumorji (tumorji mod) spadajo med redke vrste raka, med mlajšimi moškimi, starimi od 20 do 40 let, pa je to najpogostejša vrsta raka. Če diagnostiko in zdravljenje bolnikov z germinalnim tumorjem vodijo strokovnjaki z izkušnjami na te

Externí odkaz: https://doaj.org/article/9343bb7b0b314d178b4cd76d864a1230

Optimizing treatment for patients with metastatic renal cell carcinoma in the central and Eastern European region

Autor: Luboš Petruželka, Cezary Szczylik, Gunta Purkalne, G Kharkevich, Tudor Eliade Ciuleanu, Laszlo Torday, Breda Skrbinc, Eduard Vrdoljak, Yaroslav Shparyk, Jozef Mardiak, Peeter Padrik, Michal Mego

Publikováno v: Expert Opinion on Pharmacotherapy. 13:159-174

INTRODUCTION: Belarus, Bulgaria, Croatia, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Republic of Moldova, Romania, Russian Federation, Serbia, Slovakia, Slovenia and the Ukraine represent a collection of Central and Eastern European

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::922bd086cd62bd0663cfffecfa5623bb
https://doi.org/10.1517/14656566.2012.647406

Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma.

Autor: Fischer S; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Tandstad T; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Wheater M; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Porfiri E; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Fléchon A; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Aparicio J; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Klingbiel D; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Skrbinc B; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Basso U; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Shamash J; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Lorch A; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Dieckmann KP; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Cohn-Cedermark G; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Ståhl O; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Chau C; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Arriola E; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Marti K; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Hutton P; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Laguerre B; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Maroto P; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Beyer J; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden., Gillessen S; Stefanie Fischer and Silke Gillessen, Cantonal Hospital St Gallen, St Gallen; Dirk Klingbiel, SAKK Coordinating Center, Bern; Jörg Beyer, Universitätsspital Zürich, Zürich, Switzerland; Torgrim Tandstad, St Olavs University Hospital, Trondheim, Norway; Matthew Wheater, Caroline Chau, and Edurne Arriola, University Hospital Southampton, Southampton; Emilio Porfiri, Kalena Marti, and Paul Hutton, Birmingham University Hospital, Birmingham; Jonathan Shamash, St Bartholomew's Hospital, London, United Kingdom; Aude Fléchon, Centre Léon Bérard, Lyon; Brigitte Laguerre, Centre Eugène Marquis, Rennes, France; Jorge Aparicio, Hospital Universitari i Politècnic La Fe, Valencia; Pablo Maroto, Hospital Sant Pau, Barcelona, Spain; Breda Skrbinc, Institute of Oncology, Ljubljana, Slovenia; Umberto Basso, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy; Anja Lorch, Universitätsklinikum Düsseldorf, Düsseldorf; Klaus-Peter Dieckmann, Klinik für Urologie, Hamburg, Germany; Gabriella Cohn-Cedermark, Karolinska Institute; Gabriella Cohn-Cedermark, Karolinska University Hospital, Stockholm; and Olof Ståhl, Skane University Hospital, Lund, Sweden.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2017 Jan 10; Vol. 35 (2), pp. 194-200. Date of Electronic Publication: 2016 Nov 28.